Mode
Text Size
Log in / Sign up

Viral pneumonia

Part of Pneumonia

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for viral pneumonia

5 trials tracked for viral pneumonia: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 10 citations.

5Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 1 Phase 2 2 Phase 1 1 Other / NA 1
  1. Phase 3 Study on Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients With Severe COVID-19 Pneumonia. Completed · 10 cited
  2. Phase 2 Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS Completed
  3. Phase 2 Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 Completed
  4. Phase 1 A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC (Phase 1) Completed
  5. N/A Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Viral pneumonia: what the trials found

Clinical data regarding Reparixin in patients with viral pneumonia did not demonstrate a statistically significant difference in the proportion of patients alive and free of respiratory failure at Day 28 (p=0.216) or Day 60 (p=0.377) 1.

Mortality rates up to Day 28 for patients treated with Reparixin did not show a statistically significant difference (p=0.17) 1.

Recent results — preliminary, needs further review

  • Ibudilast was evaluated in a Phase 2 trial regarding hospital discharge rates at days 7, 14, and 28, but results are not yet corroborated 2.
  • 99mTc-pertechnetate aerosol inhalation was assessed for safety monitoring in patients with COVID-19 viral pneumonia, reporting neutrophil percentages ranging from 68.4% to 76.3% 3.
  • COVIVAC was evaluated in a Phase 1 trial measuring Geometric Mean Fold Rise (GMFR) 4.
  • Incentive Spirometer/Respiratory Exerciser was assessed in a small cohort 5.

For the clinician treating this condition

  • Reparixin did not demonstrate statistically significant improvements in survival, freedom from respiratory failure, or mortality rates in patients with viral pneumonia 1.
  • Current evidence for Reparixin does not support its use as a superior intervention for improving clinical outcomes at 28 or 60 days post-treatment 1.

AI synthesis of 5 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Pneumonia

Related studies from across the Pneumonia family.

Oral amoxicillin or amoxicillin-clavulanate is non-inferior to intravenous treatment for severe CAP in children
Pediatrics RCT
Oral amoxicillin or amoxicillin-clavulanate is non-inferior to intravenous treatment for severe CAP in children Trial shows oral antibiotics work for children with severe pneumonia
This randomized controlled trial of 1,101 children with severe community-acquired pneumonia in sub-Saharan Africa found that step-down oral …
A large trial in Africa found that switching children from IV to oral antibiotics for pneumonia is as safe and effective as staying on IV tr…
Impact of Systemic Prophylactic Antibacterials on Ventilator Associated Pneumonia in ICU Patients
Infectious Disease Meta-analysis
Impact of Systemic Prophylactic Antibacterials on Ventilator Associated Pneumonia in ICU Patients Antibacterials may lower pneumonia rates in patients on ventilators
Meta-analysis data suggests systemic prophylactic antibacterials significantly reduce the incidence of ventilator-associated pneumonia in IC…
A large review suggests that using certain medications can help prevent lung infections in patients requiring breathing machines in the ICU.
Nursing Care Improves Pediatric Pneumonia Outcomes
Pediatrics Meta-analysis
Nursing Care Improves Pediatric Pneumonia Outcomes Nursing care boosts satisfaction, cuts pneumonia complications in kids
Meta-analysis of 166,859 pediatric pneumonia cases shows nursing interventions boost satisfaction and cut complications.
Structured nursing care for children with pneumonia improves satisfaction and reduces complications, a large meta-analysis finds.
Precision synbiotic reduces URTI incidence from 85.4% to 55.4% in toddlers
Nutrition & Obesity Medicine RCT
Precision synbiotic reduces URTI incidence from 85.4% to 55.4% in toddlers New synbiotic formula may cut common toddler infections and eczema
This multicenter randomized controlled trial of 390 healthy toddlers aged 1-3 years found that a precision synbiotic significantly reduced u…
A new combination of a specific sugar and healthy bacteria could significantly reduce respiratory infections, diarrhea, and skin issues in t…
Protocol for comparing azithromycin and doxycycline with beta-lactams in community-acquired pneumonia
Infectious Disease RCT
Protocol for comparing azithromycin and doxycycline with beta-lactams in community-acquired pneumonia New trial to test azithromycin vs doxycycline for pneumonia
This is a protocol for a planned randomized clinical trial involving 1120 adult patients hospitalized with community-acquired pneumonia. No …
A large trial will compare two antibiotic combos for hospitalized pneumonia patients. Which works better?
AI models provide high accuracy for pulmonary inflammation and COVID-19 detection in diverse populations
Rheumatology Sys. Review
AI models provide high accuracy for pulmonary inflammation and COVID-19 detection in diverse populations Artificial Intelligence Shows Promise for Detecting Lung Inflammation
This mini-review synthesizes evidence on artificial intelligence applications for detecting pulmonary inflammation and managing perioperativ…
New research shows that artificial intelligence tools can accurately identify lung conditions like pneumonia and COVID-19 from medical imagi…
Airway clearance techniques triple odds of treatment success in Chinese pneumonia patients
Rheumatology Meta-analysis
Airway clearance techniques triple odds of treatment success in Chinese pneumonia patients Airway clearance techniques may improve treatment for pneumonia patients
This meta-analysis of RCTs in Chinese adults with pneumonia found that adding airway clearance techniques to conventional treatment signific…
Adding airway clearance to standard care may help Chinese adults with pneumonia breathe better and face fewer complications.
Short-course antibiotic therapy yields comparable clinical and bacteriological success for adults with community-acquired pneumonia
Rheumatology Meta-analysis
Short-course antibiotic therapy yields comparable clinical and bacteriological success for adults with community-acquired pneumonia Shorter antibiotics work just as well for pneumonia
This meta-analysis of 21 RCTs found that short-course antibiotic therapy (≤5 days) provides comparable clinical, bacteriological, and radiol…
For adults with pneumonia, 5 days or less of antibiotics works as well as longer courses, with fewer severe side effects.
AI diagnostic tools show high accuracy but limited real-world validation in systematic review
Oncology Meta-analysis
AI diagnostic tools show high accuracy but limited real-world validation in systematic review Artificial intelligence shows high accuracy in detecting various medical conditions
This systematic review of 24 studies synthesizes evidence on AI and deep learning for disease detection across multiple imaging modalities. …
New analysis of 24 studies shows AI tools can reach over 90% accuracy in spotting everything from lung cancer to skin disorders.
CD4+ T cells and Tim-3 regulate immune responses and cytokine-mediated injury in severe pediatric pneumonia
Gastroenterology Sys. Review
CD4+ T cells and Tim-3 regulate immune responses and cytokine-mediated injury in severe pediatric pneumonia Immune system hurdles shape severity of severe childhood pneumonia
This narrative review examines how CD4+ T cells, Tim-3 (HAVCR2), and cytokines influence the host immune response in severe pneumonia. The a…
New research explores how specific immune cells and proteins may drive the intense inflammation seen in children with severe pneumonia.
Brain-Lung-Immune-Microbiome Axis replaces biomechanical models in understanding ventilator-associated pneumonia after traumatic brain injury
Infectious Disease Sys. Review
Brain-Lung-Immune-Microbiome Axis replaces biomechanical models in understanding ventilator-associated pneumonia after traumatic brain injury New Framework Explains Lung Infections After Brain Injuries
This narrative review explores the transition from a traditional biomechanical model of ventilator-associated pneumonia to a multidimensiona…
A new model suggests that brain injuries create a complex immune and microbiome response that leads to lung infections in intensive care pat…
Adrenergic receptor signaling modulates pulmonary innate immunity and barrier integrity in acute lung injury
Diabetes & Endocrinology Sys. Review
Adrenergic receptor signaling modulates pulmonary innate immunity and barrier integrity in acute lung injury Understanding How Nerve Signals Influence Lung Health During Severe Respiratory Infections
This systematic review synthesizes the role of adrenergic receptors (ARs) as a molecular interface between the sympathetic nervous system an…
New research explores how specific nerve signals help control inflammation and protect the lungs during severe lung infections.